Back to the list
Congress: ECR24
Poster Number: C-11689
Type: EPOS Radiographer (scientific)
Authorblock: J. S. Endrikat1, A. Ullmann1, C. Gerlinger1, A. Bhatti2, P. Lengsfeld1, A. Michel3; 1Berlin/DE, 2Whippany, NJ/US, 3Basel/CH
Disclosures:
Jan Siegfried Endrikat: Author: Bayer AG Employee: Bayer AG
Alexander Ullmann: Author: Bayer AG Employee: Bayer Ag
Christoph Gerlinger: Author: Bayer AG Employee: Bayer Ag
Aasia Bhatti: Author: Bayer AG Employee: Bayer Ag
Philipp Lengsfeld: Employee: Bayer Ag Author: Bayer AG
Alexander Michel: Employee: Bayer Ag Author: Bayer AG
Keywords: Contrast agents, CT, Contrast agent-intravenous, Safety, Drugs / Reactions
References
  1. Kopp AF, Mortele KJ, Cho YD, Palkowitsch P, Bettmann MA, Claussen CD. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol. 2008;49(8):902-11.
  2. Palkowitsch P, Lengsfeld P, Stauch K, Heinsohn C, Kwon ST, Zhang SX, Liang CH. Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE). Acta Radiol. 2012;53(2):179-86.
  3. Palkowitsch PK, Bostelmann S, Lengsfeld P. Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients. Acta Radiol. 2014;55(6):707-14.
  4. Chen JY, Liu Y, Zhou YL, Tan N, Zhang B, Chen PY, Chen LB. Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST 
GALLERY